Tag: Shyam S. Bhartia
Jubilant Bhartia Foundation & McGill University collaborate to launch CoE in...
This partnership will leverage McGill University’s research led AI ecosystem to create an innovative program that integrates strong theoretical foundations with practical implementation
Jubilant launches JUBI-R, its generic version of COVID-19 drug remdesivir in...
Jubilant Generics, a subsidiary of Jubilant Life Sciences has launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of INR 4,700 per vial of 100 mg (lyophilized injection)........................
Jubilant signs agreement with Gilead for Remdesivir, a potential therapy for...
Jubilant Life Sciences Limited got the rights to register, manufacture and sell Gilead’s investigational drug, remdesivir, a potential therapy for Covid-19 in 127 countries including India.....................